[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_1588",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_1588"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB00908"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"Quinidine is contraindicated in patients who are known to be allergic to it, or who have a history of immune thrombocytopenia or have developed thrombocytopenic purpura during prior therapy with quinidine or quinine (see    WARNINGS In the absence of a functioning artificial pacemaker, quinidine is also contraindicated in any patient whose cardiac rhythm is dependent upon a junctional or idioventricular pacemaker, including patients in complete atrioventricular block. Quinidine is also contraindicated in patients who, like those with myasthenia gravis, might be adversely affected by an anticholinergic agent.\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB00908",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-23T13:11:49.292+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "jIc7djimlAJs5niXkb9b4s5Wy9++WwZWw6vZWEKTLUf7TtsktHliwes+7qe1D7p83kNZju//E2qDUxwhO714ZEFvbQgVkr16MUeO681ot2YOXSUaK+1Y7NSi0rmfGXxMS0XdBOarwzrrD9QMDW8xSUBEZPNWcJbEHaw0rHJFu0g="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg"
    } ]
  } ],
  "@id" : "http://purl.org/np/RABiZQS9B4GdFklPa9XDMtTHAVJlMDNi-ZsSWaAPUx9Lg#pubinfo"
} ]